Effect of Saliva miltiorrhiza Bunge on Antimicrobial Activity and Resistant Gene Regulation against Methicillin-Resistant Staphylococcus aureus (MRSA)

  • Lee, Ji-Won (Department of Food Science and Technology, Keimyung University) ;
  • Ji, Young-Ju (Department of Food Science and Technology, Keimyung University) ;
  • Lee, Syng-Ook (Department of Food Science and Technology, Keimyung University) ;
  • Lee, In-Seon (Department of Food Science and Technology, Keimyung University)
  • Published : 2007.08.30

Abstract

This study was conducted in an effort to evaluate the antimicrobial activity and antibiotic-resistant gene regulation from Saliva miltiorrhiza Bunge on methicillin-resistant Staphylococcus aureus (MRSA). A variety of solvent fractions and methanol extracts of S. miltiorrhiza Bunge were tested in order to determine its antimicrobial activities against S. aureus and MRSA. As a result, the hexane fraction of S. miltiorrhiza Bunge evidenced the highest levels of antimicrobial activity against S. aureus and MRSA. The MICs of the hexane fraction against various MRSA specimens were $64. The hexane fraction evidenced inhibitory effects superior to those of the chloroform fraction. The results showed inhibition zones of hexane (16 mm) and chloroform (14 mm) fractions against MRSA KCCM 40511 at $1,000{\mu}g/disc$. The hexane and chloroform fractions inhibited the expression of the resistant genes, mecA, mecR1, and femA in mRNA. Moreover, the results of Western blotting assays indicated that the hexane and chloroform fractions inhibited the expression of the resistant protein, PBP2a. These results reveal that the hexane and chloroform fractions of S. miltiorrhiza Bunge may prove to be a valuable choice for studies targeted toward the development of new antimicrobial agents.

Keywords

References

  1. Adams, J.D., M. Wall, and C. Garcia. 2005. Salvia columbariae contains tanshinones. Evidence Based Complement. Altern. Med. 2, 107-110 https://doi.org/10.1093/ecam/neh067
  2. Bailie, G. and D. Neal. 1988. Vancomycin ototoxicity and netphrotoxity. Med. Toxicol. 3, 376 https://doi.org/10.1007/BF03259891
  3. Battaglia, A., G. Bruni, A. Ardia, and G. Sachetti. 1989. On behalf of the Italian Nicergoline study group. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study. J. Am. Geriatr. Soc. 37, 295-302
  4. Berger-Bachi, B., L. Barberis-Maino, A. Strassle, and F.H. Kayser. 1989. FemA, a host-mediated factor essential for methicillin resistant in Staphylococcus aureus: molecular cloning and characterization. Mol. Gen. Genet. 219, 263-269
  5. Berger-Bachi, B., A. Strassle, J.E. Gustafson, and F.H. Kayser. 1992. Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 36, 1367-1373 https://doi.org/10.1128/AAC.36.7.1367
  6. Bertrand, G., M.E. Jose, and M. Philippe. 2005. $\beta$-Lactams against methicillin-resistant Staphylococcus aureus. Cur. Opin. Pharmacol. 5, 479-489 https://doi.org/10.1016/j.coph.2005.06.002
  7. Bramley, A.J., A.H. Patel, M. O'Reilly, R. Foster, and T.J. Foster. 1989. Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect. Immun. 57, 2489-2494
  8. Cao, E.H., X.Q. Liu, J.J. Wang, and N.F. Xu. 1996. Effect of natural antioxidant tanshinone IIA on DNA damage by lipid peroxidation in liver cells. Free Rad. Biol. Med. 20, 801-806 https://doi.org/10.1016/0891-5849(95)02211-2
  9. Chang, H.M., K.P. Cheng, T.F. Chaong, H.F. Chow, K.Y. Chui, P.M. Hon, F.W. Tan, Y. Yang, Z.P. Zhong, C.M. Lee, H.L. Sham, C.F. Chan, Y.X. Cui, and H.N. Wong. 1990. Structure elucidation and total synthesis of new tanshinones isolated from Salvia miltiorrhiza Bunge (Danshen). J. Org. Chem. 55, 3537-3543 https://doi.org/10.1021/jo00298a029
  10. Chang, H.M., K.Y. Chui, F.W.L. Tan, Y. Yang, Z.P. Zhong, C.M. Lee, H.L. Sham, and H.N. Wong. 1991. Structure activity relationship of miltirone, an active central benzodiazepine receptor ligand isolated from Salvia miltiorrhiza Bunge (danshen). J. Med. Chem. 34, 1675-1692 https://doi.org/10.1021/jm00109a022
  11. Chen, Y.H., S.J. Lin, H.H. Ku, M.S. Shiao, F.Y. Lin, J.W. Chen, and Y.L. Chen. 2001a. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J. Cell Biochem. 82, 512-521 https://doi.org/10.1002/jcb.1176
  12. Chen, Y.L., S.P. Yang, M.S. Shiao, J.W. Chen, and S.J. Lin. 2001b. Salvia miltiorrhiza inhibits intimal hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol- fed rabbits. J. Cell Biochem. 83, 484-493 https://doi.org/10.1002/jcb.1233
  13. Dutton, E.K., S.A. Ottum, T.C. Bolken, C.A. Franke, and D.E. Hruby. 2000. Expression of active monomeric and dimeric nuclease A from the Gram-positive Streptococcus gordonii surface protein expression system. Protein Expr. Purif. 19, 158-172 https://doi.org/10.1006/prep.2000.1223
  14. Hiramatsu, K., L. Cui, M. Kuroda, and T. Ito. 2001. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9, 486-493 https://doi.org/10.1016/S0966-842X(01)02175-8
  15. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F.C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40, 135-136 https://doi.org/10.1093/jac/40.1.135
  16. Hung, H.H., Y.L. Chen, S.J. Lin, S.P. Yang, C.C. Shih, M.S. Shiao, and C.H. Chang. 2001. A salvianolic acid B-rich fraction of Salvia miltiorrhiza induces neointimal cell apoptosis in rabbit angioplasty model. Histol. Histopathol. 16, 175-183
  17. Iinuma, M., H. Tsuchiya, M. Sato, J. Yokoyama, M. Ohyama, Y. Ohkawa, T. Tanaka, S. Fujiwara, and T. Fuji. 1994. Flavonones with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. J. Pharm. Pharmacol. 46, 892-895 https://doi.org/10.1111/j.2042-7158.1994.tb05709.x
  18. Ji, X.Y., B.K.H. Tan, and Y.Z. Zhu. 2000. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol. Sin. 21, 1089-1094
  19. Ji, X.Y., B.K.H. Tan, Y.C. Zhu, W. Linz, and Y.Z. Zhu. 2003. Comparison of cardio-protective effects using ramipril and danshen for the treatment of acute myocardial infarction in rats. Life Sci. 73, 1413-1426 https://doi.org/10.1016/S0024-3205(03)00432-6
  20. Kang, B.Y., S.W. Chung, S.H. Kim, S.Y. Ryu, and T.S. Kim. 2000. Inhibition of interleukin-12 and interferon gamma production in immune cells by tanshinones from Salvia miltiorrhiza. Immunopharmacol. 49, 355-361 https://doi.org/10.1016/S0162-3109(00)00256-3
  21. Kim, S.Y., T.C. Moon, H.W. Chang, K.H. Son, S.S. Kang, and H.P. Kim. 2002. Effects of tanshinone I isolated from Salvia miltiorrhiza Bunge on arachidonic acid metabolism and in vivo inflammatory response. Phytother. Res. 16, 616-620 https://doi.org/10.1002/ptr.941
  22. Lam, B.Y., A.C. Lo, X. Sun, H.W. Luo, S.K. Chung, and N.J. Sucher. 2003. Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomed. 10, 286-291 https://doi.org/10.1078/094471103322004776
  23. Lay, I.S., J.H. Chiu, M.S. Shiao, W.Y. Lui, and C.W. Wu. 2003. Crude extract of Salvia miltiorrhiza and savianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta. Med. 69, 26-32 https://doi.org/10.1055/s-2003-37034
  24. Li, H.Y., Y. Li, C.H. Yan, L.N. Li, and X.G. Chen. 2002. Inhibition of tumor growth by S-3-1, a synthetic intermediate of salvianolic acid A. J. Asian Nat. Prod. Res. 4, 271-280 https://doi.org/10.1080/1028602021000049069
  25. Li, L.N. 1997. Water soluble active components of Salvia miltiorrhiza and related plants. J. Chin. Pharm. Sci. 6, 57-64
  26. Li, X.H. and R.Y. Tang. 1991. Relationship between inhibitory action of tanshinone on neutrophil function and its prophylactic effects on myocardial infarction (Chinese). Zhongguo. Yaoli. Xuebao. 12, 269-272
  27. Liu, J., H.M. Shen, and C.N. Ong. 2001. Role of intracellular thiol depletion, mitochondrial function and reactive oxygen species in Salvia miltiorrhiza-induced apoptosis in human hepatoma HepG2 cells. Life Sci. 69, 1833-1850 https://doi.org/10.1016/S0024-3205(01)01267-X
  28. Myscofski, D.M., E.K. Dutton, E. Cantor, A. Zhang, and D.E. Hruby. 2001. Cleavage and purification of intein fusion proteins using Streptococcus gordonii spex system. Prep. Biochem. Biotechnol. 31, 275-290 https://doi.org/10.1081/PB-100104909
  29. National Committee for Clinical Laboratory Standards. 1999. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS Document M7-A2. Villanova, Pensylvania, USA
  30. Nostro, A., G. Bisignano, M. Angela Cannatelli, G. Crisafi, M. Paola Maria, and V. Alonzo. 2001. Effects of Helichrysum italicum extract on growth and enzymatic activity of Staphylococcus aureus. Int. J. Antimicrob. Agents 17, 517-520 https://doi.org/10.1016/S0924-8579(01)00336-3
  31. Park, C.G., K.H. Bang, S.E. Lee, M.S. Cha, J.S. Seong, S.U. Park, and N.S. Seong. 2001. Antimicrobial effect of various medicinal herb on Staphylococcus aureus. Korean J. Medicinal Crop. Sci. 9, 251-258
  32. Renet, C., G.H. Du, and J.T. Zhang. 2002. Inhibitory effect of the water-soluble extract of Salvia miltiorrhiza on neutrophil-endothelial adhesion. Jpn. J. Pharmacol. 90, 276-280 https://doi.org/10.1254/jjp.90.276
  33. Ryu, S.Y., Z. No, S.H. Kim, and J.W. Ahn. 1997. Two novel abietane diterpenes from Salvia miltiorrhiza. Planta Med. 63, 44-46 https://doi.org/10.1055/s-2006-957601
  34. Sabath, L.D. 1982. Mechanisms of resistant to beta-lactam antibiotics in strains of Staphylococcus aureus. Ann. Intern. Med. 97, 339-344 https://doi.org/10.7326/0003-4819-97-3-339
  35. Saletu, B., E. Paulus, and L. Lizmayer, 1995. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia or double-blind, placebo-controlled, clinical and EEG/ERP mapping study. Psychopharmacology 117, 385-395 https://doi.org/10.1007/BF02246209
  36. Sato, M., T. Sato, Y. Ose, H. Nagase, H. Kito, and Y. Sakai. 1992. Modulating effect of tanshinones on mutagenic activity of Trp- P-1 and benzo[a]pyrene in Salmonella typhimurium. Mutat. Res. 265, 149-154 https://doi.org/10.1016/0027-5107(92)90043-2
  37. Sato, M., H. Tsuchiya, I. Takase, H. Kureshiro, S. Tanigaki, and M. Iinuma. 1995. Antibacterial activity of flavonone isolated from Sophora exigua against methicillin-resistant Staphylococcus aureus and its combination with antibiotics. Phytother. Res. 9, 509-512 https://doi.org/10.1002/ptr.2650090709
  38. Schouten, M.A., J.A.A. Hoogkamp-Korstanje, J.F.G. Meis, and A. Voss. 2000. The European VRE study group prevalence of vancomycin- resistant enterococci in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 19, 816-822 https://doi.org/10.1007/s100960000390
  39. Sun, J., S.H. Huang., B.K. Tan, M. Whiteman, Y.C. Zhu, Y.J. Wu, Y. NG, W. Duan, and Y.Z. Zhu. 2005. Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction. Life Sci. 76, 2849-2860 https://doi.org/10.1016/j.lfs.2004.11.016
  40. Tang, W. and G. Eisenbrand. 1992. Chinese drug of plant origin: chemistry, pharmacology, and use in traditional and modern medicine, p. 891-902. Springer-Verlag, Berlin, Germany
  41. Yu, S., P. Kuang, T. Kanazawa, K. Onodera, H. Metoki, and Y. Oike. 1998. The effects of radix Salvia miltiorrhizae on lipid accumulation of peroxidized low density lipoprotein in mouse peritoneal macrophages-lipid analysis and morphological studies. J. Tradit. Chin. Med. 18, 292-299
  42. Wang, J.M., H.B. He, Y.Q. Zhu, D.W. Shi, Y.M. Li, and Y. Zhang. 1991. Reversed phase HPLC determination of danshensu and protocatechuic aldehyde in Salvia miltiorrhiza. Acta. Acad. Med. Shanghai 18, 27-32
  43. Wang, N., H.W. Luo, M. Niwa, and J. Ji. 1989. A new platelet aggregation inhibitor from Salvia miltiorrhiza. Planta Med. 55, 390-391 https://doi.org/10.1055/s-2006-962037
  44. Wang, A.M., S.H. Sha, W. Lesniak, and J. Schacht. 2003. Tanshinone (Salvia miltiorrhizae extract) preparations attenuate aminoglycoside induced free radical formation in vitro and ototoxicity in vivo. Antimicrob. Agents Chemother. 47, 1836-1841 https://doi.org/10.1128/AAC.47.6.1836-1841.2003
  45. World Health Organization (WHO); the promotion and development of traditional medicine. 1978. Technical report series, p. 279
  46. Wu, B., M. Liu, and S. Zhang. 2005. Danshen for acute ischaemic stroke (Review). Cochrane Library 4, 1-12
  47. Wu, Y.J., C.Y. Hong, S.J. Lin, P. Wu, and M.S. Shiao. 1998. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arterioscler. Thromb. Vasc. Biol. 18, 481-486 https://doi.org/10.1161/01.ATV.18.3.481
  48. Zhang, H.Z., C.J. Hackbarth, K.M. Chansky, and H.F. Chambers. 2001. A proteolytic transmembrane signaling pathway and resistance to $\beta$-lactams in staphylococci. Science 291, 1962-1965 https://doi.org/10.1126/science.1055144
  49. Zhou, G., W. Jiang, Y. Zhao, G. Ma, W. Xin, J. Yin, and B. Zhao. 2003. Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria. Biochem. Pharmacol. 65, 51-57 https://doi.org/10.1016/S0006-2952(02)01447-8